Folger Nolan Fleming Douglas Capital Management’s Eli Lilly LLY Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.79M	Sell	4,824 -14	-0.3%	-$14.3K	0.47%	51
2026 Q1	$4.45M	Hold	4,838	–	–	0.4%	54
2025 Q4	$5.2M	Sell	4,838 -15	-0.3%	-$14.3K	0.53%	48
2025 Q3	$3.7M	Hold	4,853	–	–	0.39%	51
2025 Q2	$3.78M	Hold	4,853	–	–	0.42%	49
2025 Q1	$4.01M	Sell	4,853 -50	-1%	-$41.6K	0.45%	49
2024 Q4	$3.79M	Sell	4,903 -218	-4%	-$181K	0.4%	49
2024 Q3	$4.54M	Sell	5,121 -50	-1%	-$45K	0.45%	48
2024 Q2	$4.68M	Sell	5,171 -35	-0.7%	-$28K	0.48%	47
2024 Q1	$4.05M	Sell	5,206 -10	-0.2%	-$7.12K	0.41%	49
2023 Q4	$3.04M	Sell	5,216 -50	-0.9%	-$29.2K	0.33%	50
2023 Q3	$2.83M	Sell	5,266 -50	-0.9%	-$25.8K	0.33%	49
2023 Q2	$2.49M	Sell	5,316 -6	-0.1%	-$2.52K	0.27%	58
2023 Q1	$1.83M	Hold	5,322	–	–	0.21%	61
2022 Q4	$1.95M	Buy	5,322 +500	+10%	+$177K	0.23%	61
2022 Q3	$1.56M	Hold	4,822	–	–	0.21%	63
2022 Q2	$1.56M	Hold	4,822	–	–	0.21%	64
2022 Q1	$1.38M	Hold	4,822	–	–	0.15%	76
2021 Q4	$1.33M	Hold	4,822	–	–	0.15%	79
2021 Q3	$1.11M	Hold	4,822	–	–	0.13%	87
2021 Q2	$1.11M	Hold	4,822	–	–	0.13%	87
2021 Q1	$901K	Hold	4,822	–	–	0.11%	93
2020 Q4	$814K	Hold	4,822	–	–	0.11%	94
2020 Q3	$714K	Hold	4,822	–	–	0.11%	95
2020 Q2	$792K	Hold	4,822	–	–	0.13%	85
2020 Q1	$669K	Sell	4,822 -11	-0.2%	-$1.51K	0.13%	87
2019 Q4	$635K	Hold	4,833	–	–	0.09%	97
2019 Q3	$540K	Buy	4,833 +11	+0.2%	+$1.23K	0.08%	100
2019 Q2	$534K	Hold	4,822	–	–	0.08%	108
2019 Q1	$626K	Hold	4,822	–	–	0.09%	97
2018 Q4	$558K	Hold	4,822	–	–	0.09%	97
2018 Q3	$517K	Hold	4,822	–	–	0.07%	106
2018 Q2	$411K	Hold	4,822	–	–	0.06%	113
2018 Q1	$373K	Hold	4,822	–	–	0.06%	121
2017 Q4	$407K	Buy	4,822 +756	+19%	+$64.3K	0.06%	119
2017 Q3	$348K	Hold	4,066	–	–	0.05%	123
2017 Q2	$335K	Hold	4,066	–	–	0.05%	127
2017 Q1	$342K	Hold	4,066	–	–	0.05%	130
2016 Q4	$337K	Hold	4,066	–	–	0.06%	127
2016 Q3	$337K	Hold	4,066	–	–	0.06%	127
2016 Q2	$320K	Hold	4,066	–	–	0.06%	130
2016 Q1	$293K	Hold	4,066	–	–	0.05%	129
2015 Q4	$343K	Hold	4,066	–	–	0.06%	122
2015 Q3	$340K	Hold	4,066	–	–	0.07%	121
2015 Q2	$339K	Hold	4,066	–	–	0.06%	124
2015 Q1	$295K	Hold	4,066	–	–	0.05%	131
2014 Q4	$281K	Buy	4,066 +800	+24%	+$54K	0.05%	136
2014 Q3	$212K	Hold	3,266	–	–	0.04%	144
2014 Q2	$203K	Buy	+3,266	New	+$195K	0.04%	150

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's LLY Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Eli Lilly (LLY) stake by 0.29% in Q2 2026, selling an estimated $14.3K and leaving 4,824 shares worth $5.79M. The position accounts for 0.47% of the portfolio, ranked #51.

Folger Nolan Fleming Douglas Capital Management first reported a position in LLY in Q2 2014 and has held it in 49 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Folger Nolan Fleming Douglas Capital Management held 4,824 shares of Eli Lilly worth $5.79M as of Q2 2026.
Folger Nolan Fleming Douglas Capital Management sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
Eli Lilly made up 0.47% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #51 holding.
Folger Nolan Fleming Douglas Capital Management first reported a position in Eli Lilly in Q2 2014 and has held it in 49 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.